France Gives Fresh Impetus To Economic Evaluations In Five Year Strategic Plan

 
• By Francesca Bruce
  
French HTA HAS it will work on managing uncertainty associated with innovative new products as part of its new five-year strategy. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from France

More from Market Access